This is the second in a two-part series on the opportunities in markets outside of North America. Read part one here. While ...

Canopy’s stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.

Roth/MKM maintained a positive stance on Canopy Growth (NASDAQ:CGC) shares, despite reducing the price target to C$10 from the previous C$15. The firm continues to endorse a Buy rating for the ...

Canadian cannabis producer cuts debt load and shows revenue growth in key segments while pushing ahead with U.S. expansion.

Be cautious ahead of Canopy Growth Corporation's FQ3 results, as weak financials and low margins may hinder stock performance ...

Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.

Tilray, Aurora Cannabis, Canopy Growth, Turning Point Brands, and Innovative Industrial Properties are the five Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis ...

Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.

Canopy Growth (TSE:WEED – Get Free Report) had its target price lowered by equities research analysts at ATB Capital from C$4.00 to C$3.20 in a research note issued on Monday,BayStreet.CA reports. The ...

Canopy Growth Corp.’s stock fell sharply as the Canadian cannabis company’s wider-than-expected third-quarter loss chilled a recent rally in its share price. At the closing bell, Canopy Growth ...

I would like to welcome you to Canopy Growth's third-quarter fiscal 2025 financial results conference call. Currently, all ...

Canopy Growth Corp.'s stock fell sharply as the Canadian cannabis company's wider-than-expected third-quarter loss chilled a recent rally in its share price. Canopy Growth's stock fell 18% to $2. ...